Lamotrigine EP Impurity E (Lamotrigine USP Related Compound B)(CAS: 50-45-3)

Lamotrigine EP Impurity E (Lamotrigine USP Related Compound B), with CAS number 50-45-3, is a structural impurity associated with lamotrigine, an anticonvulsant medication. It is chemically related to lamotrigine (C13H12N2O2S) and may arise during synthesis or degradation. This compound is typically analyzed in pharmaceutical quality control to ensure drug purity and safety.

Lamotrigine EP Impurity E (Lamotrigine USP Related Compound B) is primarily used in pharmaceutical research and quality control to identify and quantify impurities in lamotrigine preparations. It also serves as a reference standard for analytical methods, such as HPLC, to assess drug purity and compliance with regulatory specifications.

Lamotrigine EP Impurity E (Lamotrigine USP Related Compound B) is generally considered safe when present within acceptable limits in pharmaceutical products, as per regulatory guidelines. However, direct handling should follow standard safety protocols, including PPE use and adherence to safety data sheets. Its toxicity profile is less well-documented compared to the parent compound, lamotrigine.

Lamotrigine EP Impurity E (Lamotrigine USP Related Compound B) should be stored in a cool, dry place (2-8°C), protected from light, and in a sealed container to maintain stability. Avoid exposure to moisture and humidity above 60%. Proper storage ensures its integrity as a reference standard for analytical testing.